Kangji Medical Holdings Limited (9997.HK)

HKD 7.3

(-0.82%)

EBITDA Summary of Kangji Medical Holdings Limited

  • Kangji Medical Holdings Limited's latest annual EBITDA in 2023 was 464.58 Million CNY , up 34.5% from previous year.
  • Kangji Medical Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 240.7 Million CNY , down 0.0% from previous quarter.
  • Kangji Medical Holdings Limited reported an annual EBITDA of 586.65 Million CNY in 2022, up 7.79% from previous year.
  • Kangji Medical Holdings Limited reported an annual EBITDA of 427.25 Million CNY in 2021, up 33.87% from previous year.
  • Kangji Medical Holdings Limited reported a quarterly EBITDA of 192.84 Million CNY for 2023 Q2, down 0.0% from previous quarter.
  • Kangji Medical Holdings Limited reported a quarterly EBITDA of N/A for 2023 FY, up 34.5% from previous quarter.

Annual EBITDA Chart of Kangji Medical Holdings Limited (2023 - 2017)

Historical Annual EBITDA of Kangji Medical Holdings Limited (2023 - 2017)

Year EBITDA EBITDA Growth
2023 464.58 Million CNY 34.5%
2022 586.65 Million CNY 7.79%
2021 427.25 Million CNY 33.87%
2020 319.14 Million CNY -7.55%
2019 345.19 Million CNY 29.38%
2018 267.42 Million CNY 57.77%
2017 168.64 Million CNY 0.0%

Peer EBITDA Comparison of Kangji Medical Holdings Limited

Name EBITDA EBITDA Difference
Kaisa Health Group Holdings Limited 27.56 Million HKD -1585.646%
Elegance Optical International Holdings Limited -51.64 Million HKD 999.549%
Arts Optical International Holdings Limited 77.08 Million HKD -502.671%
Kelfred Holdings Limited 14.24 Million HKD -3161.591%
Modern Dental Group Limited 696.64 Million HKD 33.312%